Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials

CompletedOBSERVATIONAL
Enrollment

922

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Respiratory Distress Syndrome, Adult
Trial Locations (6)

21201

University of Maryland Medical Center, Baltimore

21205

Johns Hopkins University, Baltimore

27157

Wake Forest University, Winston-Salem

37232

Vanderbilt University, Nashville

84107

Intermountain Medical Center, Murray

98104

University of Washington/Harborview Medical Center, Seattle

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Johns Hopkins University

OTHER

NCT00719446 - Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials | Biotech Hunter | Biotech Hunter